SHZ · 300326.SZ
Shanghai Kinetic Medical Co., Ltd
CN¥6.37+CN¥0.03 (+0.47%)
Shanghai Kinetic Medical Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 13.1% below the high.
Loading market information…
SHZ · 002932.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.86% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.’s forward annual dividend is CN¥2.40 per share, paid semi-annual. The forward yield is 16.88% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.’s next earnings report is currently expected on Oct 31, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Wuhan Easy Diagnosis Biomedicine Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. specializes in the research, development, manufacturing, and global distribution of in vitro diagnostic (IVD) reagents and related equipment. Their extensive product line features molecular diagnostics, including genetic tests for drug metabolism and pathogen nucleic acid detection kits, alongside immunodiagnostic and blood gas analysis solutions. Beyond diagnostics, the company delivers comprehensive information solutions for emergency and critical illness, which encompass specialized software, supporting hardware, and expert certification consulting. They also provide third-party medical testing services. These offerings are applied across a broad spectrum of medical fields, addressing conditions such as cardiovascular, kidney, infectious, diabetes, endocrine, and metabolic diseases, as well as obstetrics and gynecology. Furthermore, their products support prenatal and postnatal care, general health check-ups, and specific analyses for thyroid function, hormones, blood gases, coagulation, drug metabolism, and pathogen identification. Established in 2008, the company is headquartered in Wuhan, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥93.31M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥6.37+CN¥0.03 (+0.47%)
Shanghai Kinetic Medical Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 13.1% below the high.
CN¥8.45-CN¥0.09 (-1.05%)
Getein Biotech, Inc’s quoted price sits in the lower half of its reported 52-week range, 26.01% below the high.
CN¥13.44-CN¥0.66 (-4.68%)
Ningbo David Medical Device Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 20.47% below the high.
CN¥38.30-CN¥0.45 (-1.16%)
Nanjing Vishee Medical Technology Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 47.0% below the high.
CN¥4.45-CN¥0.08 (-1.77%)
Beijing Bohui Innovation Biotechnology Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.44% below the high.
CN¥17.08-CN¥0.50 (-2.84%)
Zhejiang Orient Gene Biotech Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.08% below the high.
CN¥5.90+CN¥0.30 (+5.36%)
Beijing Leadman Biochemistry Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.32% below the high.
CN¥15.83-CN¥0.55 (-3.36%)
Tellgen Corporation’s quoted price sits in the lower half of its reported 52-week range, 36.68% below the high.
